LQDA
HEALTHCARELiquidia Technologies Inc
AI Insight
What's Moving LQDA Today?
No stock-specific AI insight has been generated for LQDA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$11.85$76.66
$74.04
Fundamentals
Market Cap$6.7B
P/E Ratio444.1
EPS$0.17
Dividend Yield—
Dividend / Share—
ROE28.2%
Profit Margin7.7%
Debt / Equity—
Trading
Volume1.7M
Avg Volume (10D)—
Shares Outstanding88.9M
LQDA News
34 articles- EU Clears SNY's Cenrifki for Secondary Progressive Multiple SclerosisYahoo Finance·Jun 23, 2026
- Xenon Pharmaceuticals Stock Gains 22% in Six Months: Here's WhyYahoo Finance·Jun 23, 2026
- Definium Stock Soars 50% as Phase III Depression Study Meets Key GoalsYahoo Finance·Jun 23, 2026
- Regenxbio Shares Rise on Plans to Resubmit Navsunli BLA for MPS IIYahoo Finance·Jun 23, 2026
- 3 Best Low-Beta Stocks to Buy Right Away: LQDA, FLXS & AGXYahoo Finance·Jun 23, 2026
- Bull of the Day: Liquidia Corporation (LQDA)Yahoo Finance·Jun 23, 2026
- Liquidia and Goodyear have been highlighted as Zacks Bull and Bear of the DayYahoo Finance·Jun 23, 2026
- QURE Announces Initial Data on Gene therapy for Temporal Lobe EpilepsyYahoo Finance·Jun 22, 2026
- Liquidia (LQDA) Presented New YUTREPIA Data With A Closer Look At CaregiversYahoo Finance·Jun 21, 2026
- QURE Soars as FDA Backs AMT-130 Data for Accelerated ApprovalYahoo Finance·Jun 19, 2026
- BEAM Stock Gains 5% as FDA Clears BEAM-304 IND for PhenylketonuriaYahoo Finance·Jun 19, 2026
- Can Vertex's Kidney Pipeline Power Its Next Growth Phase?Yahoo Finance·Jun 19, 2026
- MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel BackingYahoo Finance·Jun 19, 2026
- Director at Liquidia (NASDAQ: LQDA) granted 5,882 RSUs in stock awardStock Titan·Jun 18, 2026
- AGIO Stock Surges 35% in Six Months: What's Driving It?Yahoo Finance·Jun 18, 2026
- JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor TherapiesYahoo Finance·Jun 18, 2026
- Corcept Resubmits NDA for Relacorilant in Cushing's SyndromeYahoo Finance·Jun 18, 2026
- Strong backing as Liquidia (NASDAQ: LQDA) holders approve board, auditor and payStock Titan·Jun 17, 2026
- DNTH Shares Surge 89% Over the Past Six Months: What's Driving It?Yahoo Finance·Jun 17, 2026
- OTLK Stock Up 35% as FDA Accepts Resubmitted Eye Drug BLA for ReviewYahoo Finance·Jun 17, 2026
- MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)Yahoo Finance·Jun 17, 2026
- NTLA Posts Strong Additional Phase III Data From HAE Study, Stock UpYahoo Finance·Jun 16, 2026
- Liquidia director Paul B. Manning sells $12.8 million in sharesInvesting.com·Jun 9, 2026
- Liquidia (LQDA) director Paul Manning sells 200,000 shares but retains large stakeStock Titan·Jun 9, 2026
- Liquidia Corp CEO Roger Jeffs sells $4.58 million in sharesInvesting.com·May 27, 2026
- Liquidia Corp CEO Roger Jeffs sells $4.58 million in sharesInvesting.com·May 26, 2026
- Liquidia (LQDA) director sells 29,494 shares after option exerciseStock Titan·May 26, 2026
- Liquidia (LQDA) CEO sells 75K shares under Rule 10b5-1 planStock Titan·May 26, 2026
- Liquidia (NASDAQ:LQDA) Raised to Strong-Buy at Wall Street ZenMarketBeat·May 16, 2026
- Affiliate plans sales for LQDA (NASDAQ: LQDA) — multiple 10b5-1 trades listedStock Titan·May 8, 2026
- Liquidia CEO Roger Jeffs sells $3.07m in company stock By Investing.comInvesting.com Australia·May 8, 2026
- Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsightGlobeNewswire Inc.·Apr 8, 2026
- Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?The Motley Fool·Apr 5, 2026
- The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8MThe Motley Fool·Mar 28, 2026
All 34 articles loaded
Price Data
Open$74.33
Previous Close$75.49
Day High$77.09
Day Low$73.80
52 Week High$76.66
52 Week Low$11.85
52-Week Range
$11.85$76.66
$74.04
Fundamentals
Market Cap$6.7B
P/E Ratio444.1
EPS$0.17
Dividend Yield—
Dividend / Share—
ROE28.2%
Profit Margin7.7%
Debt / Equity—
Trading
Volume1.7M
Avg Volume (10D)—
Shares Outstanding88.9M
About Liquidia Technologies Inc
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—